A Detailed Analysis of the Oncology Nutrition Market Based on Rising Healthcare Expenditure, and Rampant growth in Prevalence of Cancers
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 186
Report ID: PMRREP33730
1. Executive Summary
1.1. Global Oncology Nutrition Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Cancer Type Lifecycle Analysis
2.4. Oncology Nutrition Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Oncology Nutrition Market Outlook: Cancer Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Cancer Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
3.3.3.1. Head and Neck Cancers
3.3.3.2. Stomach and Gastrointestinal Cancers
3.3.3.3. Liver Cancer
3.3.3.4. Pancreatic Cancer
3.3.3.5. Esophageal Cancer
3.3.3.6. Lung Cancer
3.3.3.7. Breast Cancer
3.3.3.8. Blood Cancer
3.3.3.9. Other Cancers
3.4. Market Attractiveness Analysis: Cancer Type
3.5. Global Oncology Nutrition Market Outlook: End Use
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End Use, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
3.5.3.1. Hospitals & Clinics
3.5.3.2. Home Care
3.5.3.3. Others
3.6. Market Attractiveness Analysis: End Use
4. Global Oncology Nutrition Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Cancer Type
5.3.3. By End Use
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
5.5.1. Head and Neck Cancers
5.5.2. Stomach and Gastrointestinal Cancers
5.5.3. Liver Cancer
5.5.4. Pancreatic Cancer
5.5.5. Esophageal Cancer
5.5.6. Lung Cancer
5.5.7. Breast Cancer
5.5.8. Blood Cancer
5.5.9. Other Cancers
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
5.6.1. Hospitals & Clinics
5.6.2. Home Care
5.6.3. Others
5.7. Market Attractiveness Analysis
6. Europe Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Cancer Type
6.3.3. By End Use
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
6.5.1. Head and Neck Cancers
6.5.2. Stomach and Gastrointestinal Cancers
6.5.3. Liver Cancer
6.5.4. Pancreatic Cancer
6.5.5. Esophageal Cancer
6.5.6. Lung Cancer
6.5.7. Breast Cancer
6.5.8. Blood Cancer
6.5.9. Other Cancers
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
6.6.1. Hospitals & Clinics
6.6.2. Home Care
6.6.3. Others
6.7. Market Attractiveness Analysis
7. East Asia Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Cancer Type
7.3.3. By End Use
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
7.5.1. Head and Neck Cancers
7.5.2. Stomach and Gastrointestinal Cancers
7.5.3. Liver Cancer
7.5.4. Pancreatic Cancer
7.5.5. Esophageal Cancer
7.5.6. Lung Cancer
7.5.7. Breast Cancer
7.5.8. Blood Cancer
7.5.9. Other Cancers
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
7.6.1. Hospitals & Clinics
7.6.2. Home Care
7.6.3. Others
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Cancer Type
8.3.3. By End Use
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
8.5.1. Head and Neck Cancers
8.5.2. Stomach and Gastrointestinal Cancers
8.5.3. Liver Cancer
8.5.4. Pancreatic Cancer
8.5.5. Esophageal Cancer
8.5.6. Lung Cancer
8.5.7. Breast Cancer
8.5.8. Blood Cancer
8.5.9. Other Cancers
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
8.6.1. Hospitals & Clinics
8.6.2. Home Care
8.6.3. Others
8.7. Market Attractiveness Analysis
9. Latin America Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Cancer Type
9.3.3. By End Use
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
9.5.1. Head and Neck Cancers
9.5.2. Stomach and Gastrointestinal Cancers
9.5.3. Liver Cancer
9.5.4. Pancreatic Cancer
9.5.5. Esophageal Cancer
9.5.6. Lung Cancer
9.5.7. Breast Cancer
9.5.8. Blood Cancer
9.5.9. Other Cancers
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
9.6.1. Hospitals & Clinics
9.6.2. Home Care
9.6.3. Others
9.7. Market Attractiveness Analysis
10. Middle East & Africa Oncology Nutrition Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Cancer Type
10.3.3. By End Use
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Cancer Type, 2023 - 2030
10.5.1. Head and Neck Cancers
10.5.2. Stomach and Gastrointestinal Cancers
10.5.3. Liver Cancer
10.5.4. Pancreatic Cancer
10.5.5. Esophageal Cancer
10.5.6. Lung Cancer
10.5.7. Breast Cancer
10.5.8. Blood Cancer
10.5.9. Other Cancers
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End Use, 2023 - 2030
10.6.1. Hospitals & Clinics
10.6.2. Home Care
10.6.3. Others
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Stomach and Gastrointestinal Cancers
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Aceto
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. B. Braun Melsungen AG
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Baxter
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Fresenius Kabi AG
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Global Health Products, Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Hormel Foods Corporation
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Mead Johnson & Company, LLC
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Meiji Holdings Co., Ltd
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Nestlé S.A.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. BioSig Technologies, Inc.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Auris Health, Inc.
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
